Full Text View
Tabular View
No Study Results Posted
Related Studies
Congenital Adrenal Hyperplasia: Calcium Channels as Therapeutic Targets
This study has been completed.
Study NCT00000102   Information provided by National Center for Research Resources (NCRR)
First Received: November 3, 1999   Last Updated: June 23, 2005   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Congenital Adrenal Hyperplasia
Additional conditions recognized in this trial
Adrenal Hyperplasia, Congenital
Adrenocortical Hyperfunction
Adrenogenital Syndrome
Hyperplasia
More general conditions related to this trial
Adrenal Gland Diseases
Endocrine System Diseases
Genetic Diseases, Inborn
Gonadal Disorders
Metabolic Diseases
Metabolism, Inborn Errors
Pathologic Processes
Sex Differentiation Disorders
Steroid Metabolism, Inborn Errors
Interventions listed in this trial
Nifedipine
More general drug interventions related to this trial
Calcium Channel Blockers
Cardiovascular Agents
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Therapeutic Uses
Tocolytic Agents
Vasodilator Agents
Sponsors listed in this trial
National Center for Research Resources (NCRR)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services